1-(3,5-Dibromothiophen-2-yl)ethan-1-one, 95+%, 100mg

1-(2-methoxyethyl)-4-piperidinecarboxylic acid, 95.0%, 5g

(1-Methylethenyl)-benzene contains 15 ppm p-tert-butylcatechol as inhibitor, 95.0%, 10g

1,1,1-Trifluoroethyl-PEG2-propargyl, 1g

Di-tert-butyl 1,4,5-oxadiazepane-4,5-dicarboxylate, 97%, 5g

2,6-Dichloro-4-iodopyridine, 98.0%, 5g

ETHYL-3-PHENYL PYRAZOLE-4-CARBOXYLATE, 95.0%, 5g

(2S,3S)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one>96.0%(HPLC)(N)5g

N-Chloroacetyl-DL-norleucine>99.0%(T)1g

N-(2-Carboxybenzoyl)-(-)-10,2-camphorsultam>98.0%(HPLC)(T)500mg

Homoalanine hydrochloride, 97.0%, 1g

7-Hydroxycoumarin-3-carboxylic Acid>98.0%(HPLC)200mg

5-(3-fluorophenyl)-4H-1,2,4-triazol-3-amine, 95.0%, 5g